Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | APP | P05067 | 6/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.35 |
| ▸ | SRD5A1 | P18405 | 2/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP7 | P09237 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | MMP13 | P45452 | 1/20 | 0.33 |
| ▸ | XDH | P47989 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6998427 | 0.76 | KDM4E (0.52) | KDM4ELMNAAPPFTOMAPK1 | |
| SCHEMBL5642283 | 0.76 | — | — | |
| SCHEMBL10902278 | 0.75 | KDM4E (0.43) | KDM4ELMNAAPP | |
| SCHEMBL25948708 | 0.75 | KDM4E (0.43) | KDM4ELMNAAPP | |
| SCHEMBL561713 | 0.75 | KDM4E (0.50) | KDM4ELMNAAPPFTOMAPK1 | |
| E637 SCHEMBL41817 | 0.75 | KDM4E (0.55) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL1870685 | 0.75 | KDM4E (0.55) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL6657728 | 0.73 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| E637 SCHEMBL8026696 | 0.73 | KDM4E (0.53) | KDM4ELMNAAPPGABRA1GABRB2 | |
| SCHEMBL9700110 | 0.73 | KDM4E (0.48) | KDM4ELMNAAPPFTOMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | claimed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | claimed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | claimed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | claimed |
| WO-1989009211-A1 | PROCESS FOR PRODUCING PYRID-4-ONES | THE ROYAL FREE HOSPITAL SCHOOL OF MEDICINE (GB) | 1989-10-05 | — | — | WO | claimed |
| EP-0335745-A1 | Process for producing pyrid-4-ones | THE ROYAL FREE HOSPITAL SCHOOL OF MEDICINE (GB) | 1989-10-04 | — | — | EP | claimed |
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2025-05-22 | — | — | US | disclosed |
| EP-4469037-A1 | ANTIMICROBIAL COMPOSITIONS | Bio-Actives Synergio Ltd (IL) | 2024-12-04 | — | — | EP | disclosed |
| CN-118660702-A | Antimicrobial compositions | 生物活性协同有限公司 | 2024-09-17 | — | — | CN | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| WO-2023144808-A1 | ANTIMICROBIAL COMPOSITIONS | BIO-ACTIVES SYNERGIO LTD (IL) | 2023-08-03 | — | — | WO | disclosed |
| EP-3192793-B1 | COMPOSITIONS CONTAINING IRON HYDROXYPYRONE | SHIELD TX UK LTD (GB) | 2022-03-16 | — | — | EP | disclosed |
| EP-3116548-B1 | COMPOSITION | SHIELD TX UK LTD (GB) | 2021-02-17 | — | — | EP | disclosed |
| EP-1506183-A1 | METHOD OF FORMING IRON HYDROXYPYRONE COMPOUNDS | Vitra Pharmaceuticals Ltd. (GB) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003097627-A1 | METHOD OF FORMING IRON HYDROXYPYRONE COMPOUNDS | VITRA PHARMACEUTICALS LIMITED (GB) | 2003-11-27 | — | — | WO | disclosed |
| US-6339080-B1 | FOR THERAPY AND PROPHYLAXIS OF IRON DEFICIENCY DISORDERS INCLUDING IRON DEFICIENCY ANAEMIA | VITRA PHARMACEUTICALS LTD. (GB) | 2002-01-15 | — | — | US | disclosed |
| WO-1989009211-A1 | PROCESS FOR PRODUCING PYRID-4-ONES | THE ROYAL FREE HOSPITAL SCHOOL OF MEDICINE (GB) | 1989-10-05 | — | — | WO | disclosed |
| EP-0335745-A1 | Process for producing pyrid-4-ones | THE ROYAL FREE HOSPITAL SCHOOL OF MEDICINE (GB) | 1989-10-04 | — | — | EP | disclosed |
| US-4608367-A | γ-Pyrone phosphoric ester derivatives and insecticidal and miticidal compositions thereof | OTSUKA KAGAKU KABUSHIKI KAISHA (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4246178-A | CHEMICAL INTERMEDIATE FOR THE FLAVOR MALTOL | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1981-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161182-A1 | ANTIMICROBIAL COMPOSITIONS | NOD2, PYCARD, CLPP | KDM4E 4332/4885LMNA 2204/4885APP 2790/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.